NCT06784752 2026-03-06
NETTER-3
Novartis
Phase 3 Recruiting
Clinical Trials
4 trialsNCT06295952 2026-03-04
A Study of Pasireotide in People With Prolactinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT03972488 2026-01-21
NETTER-2
Advanced Accelerator Applications
Phase 3 Active not recruiting
NCT01313559 2025-04-30
Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Thomas Jefferson University
Phase 2 Terminated